Scott Leftwich
Known title: DirectorCIK: 0001991668
Scott Leftwich's purchase track record
Scott Leftwich has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/21/2025 | CLDI | $250K | -18.8% | -56.9% | +7.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CLDI | ▲ Buy | Open Market | 125,000 | $250K | 8/21/2025 | View on chart |
| CLDI | ▲ Buy | Grant | 11,684 | — | 12/31/2024 | View on chart |
| CLDI | ▲ Buy | Grant | 67,187 | — | 6/28/2024 | View on chart |
| CLDI | ▲ Buy | Grant | 23,783 | — | 3/29/2024 | View on chart |
| CLDI | ▲ Buy | Grant | 8,958 | $16K | 12/21/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
CLDI Included in After-Market Movers List
Calidi Biotherapeutics was listed among 12 health care stocks moving in Tuesday's after-market session. The stock is currently trading near its 52-week low of $1.03, reflecting significant volatility. This inclusion highlights recent price action in the biotech sector.
CLDI Included in After-Market Movers List. Calidi Biotherapeutics was listed among 12 health care stocks moving in Tuesday's after-market session. The stock is currently trading near its 52-week low of $1.03, reflecting significant volatility. This inclusion highlights recent price action in the biotech sector.